Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2006 2
2007 5
2008 8
2009 5
2010 8
2011 6
2012 5
2013 10
2014 14
2015 20
2016 15
2017 19
2018 10
2019 4
2020 14
2021 18
2022 16
2023 11
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae SC, Brohawn PZ, Pineda L, Berglind A, Tummala R; TULIP-2 Trial Investigators. Morand EF, et al. N Engl J Med. 2020 Jan 16;382(3):211-221. doi: 10.1056/NEJMoa1912196. Epub 2019 Dec 18. N Engl J Med. 2020. PMID: 31851795 Clinical Trial.
Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial.
Jourde-Chiche N, Costedoat-Chalumeau N, Baumstarck K, Loundou A, Bouillet L, Burtey S, Caudwell V, Chiche L, Couzi L, Daniel L, Deligny C, Dussol B, Faguer S, Gobert P, Gondran G, Huart A, Hummel A, Kalbacher E, Karras A, Lambert M, Le Guern V, Lebourg L, Loubière S, Maillard-Lefebvre H, Maurier F, Pha M, Queyrel V, Remy P, Sarrot-Reynauld F, Verhelst D, Hachulla E, Amoura Z, Daugas E; WIN-Lupus study group. Jourde-Chiche N, et al. Among authors: le guern v. Ann Rheum Dis. 2022 Oct;81(10):1420-1427. doi: 10.1136/annrheumdis-2022-222435. Epub 2022 Jun 20. Ann Rheum Dis. 2022. PMID: 35725295 Free PMC article. Clinical Trial.
Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity.
Jesus D, Larosa M, Henriques C, Matos A, Zen M, Tomé P, Alves V, Costa N, Le Guern V, Iaccarino L, Costedoat-Chalumeau N, Doria A, Inês LS. Jesus D, et al. Among authors: le guern v. Ann Rheum Dis. 2021 Dec;80(12):1568-1574. doi: 10.1136/annrheumdis-2021-220363. Epub 2021 Aug 18. Ann Rheum Dis. 2021. PMID: 34407927
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort.
Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, Maurier F, Jouneau S, Bienvenu B, Puéchal X, Aumaître O, Le Guenno G, Le Quellec A, Cevallos R, Fain O, Godeau B, Seror R, Dunogué B, Mahr A, Guilpain P, Cohen P, Aouba A, Mouthon L, Guillevin L; French Vasculitis Study Group. Comarmond C, et al. Arthritis Rheum. 2013 Jan;65(1):270-81. doi: 10.1002/art.37721. Arthritis Rheum. 2013. PMID: 23044708 Free article.
A glittering spleen.
Durel CA, Groh M, Le Guern V. Durel CA, et al. Among authors: le guern v. Joint Bone Spine. 2017 May;84(3):363. doi: 10.1016/j.jbspin.2016.04.009. Epub 2016 Jun 17. Joint Bone Spine. 2017. PMID: 27324604 No abstract available.
French national diagnostic and care protocol for Sjögren's disease.
Devauchelle-Pensec V, Mariette X, Benyoussef AA, Boisrame S, Cochener B, Cornec D, Nocturne G, Gottenberg JE, Hachulla E, Labalette P, Le Guern V, M'Bwang Seppoh R, Morel J, Orliaguet M, Saraux A, Seror R, Costedoat-Chalumeau N; Collaborators. Devauchelle-Pensec V, et al. Among authors: le guern v. Rev Med Interne. 2023 Aug;44(8):423-457. doi: 10.1016/j.revmed.2023.07.001. Epub 2023 Jul 13. Rev Med Interne. 2023. PMID: 37453854 Review.
[Liver diseases and pregnancy].
Guettrot-Imbert G, Plessier A, Hillaire S, Delluc C, Leroux G, Le Guern V, Costedoat-Chalumeau N. Guettrot-Imbert G, et al. Among authors: le guern v. Rev Med Interne. 2015 Mar;36(3):211-8. doi: 10.1016/j.revmed.2014.10.355. Epub 2015 Jan 12. Rev Med Interne. 2015. PMID: 25591870 Review. French.
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.
Felten R, Devauchelle-Pensec V, Seror R, Duffau P, Saadoun D, Hachulla E, Pierre Yves H, Salliot C, Perdriger A, Morel J, Mékinian A, Vittecoq O, Berthelot JM, Dernis E, Le Guern V, Dieudé P, Larroche C, Richez C, Martin T, Zarnitsky C, Blaison G, Kieffer P, Maurier F, Dellal A, Rist S, Andres E, Contis A, Chatelus E, Sordet C, Sibilia J, Arnold C, Tawk MY, Aberkane O, Holterbach L, Cacoub P, Saraux A, Mariette X, Meyer N, Gottenberg JE. Felten R, et al. Among authors: le guern v. Ann Rheum Dis. 2021 Mar;80(3):329-338. doi: 10.1136/annrheumdis-2020-218467. Epub 2020 Nov 18. Ann Rheum Dis. 2021. PMID: 33208345 Clinical Trial.
French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.
Amoura Z, Bader-Meunier B, Bal Dit Sollier C, Belot A, Benhamou Y, Bezanahary H, Cohen F, Costedoat-Chalumeau N, Darnige L, Drouet L, Elefant E, Harroche A, Lambert M, Martin T, Martin-Toutain I, Mathian A, Mekinian A, Pineton De Chambrun M, de Pontual L, Wahl D, Yelnik C, Zuily S; Collaborators. Amoura Z, et al. Rev Med Interne. 2023 Sep;44(9):495-520. doi: 10.1016/j.revmed.2023.08.004. Epub 2023 Sep 19. Rev Med Interne. 2023. PMID: 37735010 Review.
[2016 review on catastrophic antiphospholipid syndrome].
Costedoat-Chalumeau N, Coutte L, Le Guern V, Morel N, Leroux G, Paule R, Mouthon L, Piette JC. Costedoat-Chalumeau N, et al. Among authors: le guern v. Presse Med. 2016 Dec;45(12 Pt 1):1084-1092. doi: 10.1016/j.lpm.2016.07.023. Epub 2016 Sep 9. Presse Med. 2016. PMID: 27617783 Review. French.
167 results